CLINICAL ACCOUNT MANAGER

SANUWAVE's patented shock wave technology was evaluated in-vitro for effects on difficult to remove biofilms created by both Gram-negative bacteria (Pseudomonas aeruginosa) and Gram-positive bacteria (Staphylococcus aureus).

Biofilms were exposed to focused acoustic shockwaves and the application was performed without any contact between the shockwave applicator and the biofilm. The shockwave application to the biofilms resulted in a greater than three (3) log reductions (99.9%) from the surfaces exposed to the shockwaves in certain tests for both bacteria test species. These results indicate that SANUWAVE's technology can effectively remove biofilms from surfaces using only the mechanical stresses produced by the shock waves. These tests indicate that SANUWAVE's technology could potentially reduce or eliminate the need to use chemicals, enzymes, or antibiotics to destroy and remove biofilms.  More info here and here.

Diabetic Foot Ulcer Treatment.  Shockwave Threapy.